Re: Enzalutamide and Survival in Nonmetastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Mori, Keiichiro [1 ,2 ]
Egawa, Shin [2 ]
Shariat, Shahrokh F. [1 ]
机构：
[1] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Jikei Univ Sch Med, Dept Urol, Tokyo, Japan
来源：
EUROPEAN UROLOGY | 2021年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：430 / 431
页数：2
相关论文
共 50 条
  • [1] Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
    Sternberg, Cora N.
    Fizazi, Karim
    Saad, Fred
    Shore, Neal D.
    De Giorgi, Ugo
    Penson, David F.
    Ferreira, Ubirajara
    Efstathiou, Eleni
    Madziarska, Katarzyna
    Kolinsky, Michael P.
    Cubero, Daniel I. G.
    Noerby, Bettina
    Zohren, Fabian
    Lin, Xun
    Modelska, Katharina
    Sugg, Jennifer
    Steinberg, Joyce
    Hussain, Maha
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23): : 2197 - 2206
  • [2] Re: Enzalutamide in Men with Nonmetastatic, Castration-resistant Prostate Cancer
    Mason, Malcolm
    EUROPEAN UROLOGY, 2018, 74 (06) : 845 - 845
  • [3] Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
    Hussain, Maha
    Fizazi, Karim
    Saad, Fred
    Rathenborg, Per
    Shore, Neal
    Ferreira, Ubirajara
    Ivashchenko, Petro
    Demirhan, Eren
    Modelska, Katharina
    Phung, De
    Krivoshik, Andrew
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2465 - 2474
  • [4] Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Altavilla, Amelia
    Casadei, Chiara
    Lolli, Cristian
    Menna, Cecilia
    Ravaglia, Giorgia
    Gurioli, Giorgia
    Farolfi, Alberto
    Brighi, Nicole
    Conteduca, Vincenza
    Burgio, Salvatore Luca
    Schepisi, Giuseppe
    Rossi, Lorena
    Gargiulo, Stefania
    Lisotti, Ivana
    De Giorgi, Ugo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2091 - 2099
  • [5] Re: Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2021, 205 (04): : 1226 - 1227
  • [6] Re: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 201 (01): : 31 - 31
  • [7] Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
    Rhea, Logan P.
    Gupta, Brinda
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (02) : 107 - 108
  • [8] Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer
    Schultz, Neil M.
    O'Day, Ken
    Sugarman, Rebecca
    Ramaswamy, Krishnan
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (04): : 538 - 549
  • [9] Re: Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 202 (04): : 660 - 661
  • [10] Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
    Fizazi, Karim
    Shore, Neal
    Tammela, Teuvo L.
    Ulys, Albertas
    Vjaters, Egils
    Polyakov, Sergey
    Jievaltas, Mindaugas
    Luz, Murilo
    Alekseev, Boris
    Kuss, Iris
    Le Berre, Marie-Aude
    Petrenciuc, Oana
    Snapir, Amir
    Sarapohja, Toni
    Smith, Matthew R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11): : 1040 - 1049
12345